EFFICACY, SAFETY, AND DEMOGRAPHICS FACTOR OF ORAL TACROLIMUS THERAPY IN 666 JAPANESE PATIENTS WITH REFRACTORY ULCERATIVE COLITIS

Haruhiko Ogata  1     Takayuki Yamamoto  2     Reiko Kunisaki  3     Kota Ishida  4     Toshifumi Hibi  5    
1 School Of Medicine, Keio University, Tokyo, Japan
2 Yokkaichi Hazu Medical Center, Yokkaichi, Japan
3 Yokohama City University Medical Center, Yokohama, Japan
4 Astellas Pharma Inc., Tokyo, Japan
5 Kitasato University Kitasato Institute Hospital, Tokyo, Japan

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing